TMO vs REGN
By Alex · Tickerpine
Thermo Fisher Scientific Inc. vs Regeneron Pharmaceuticals, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | TMO | REGN |
|---|---|---|
| Price | $675.00 | $788.04 |
| Market cap | $249.58B | $81.13B |
| P/E ratio | 36.4 | 19.5 |
| ROE | 13.51% | 14.04% |
| Profit margin | 15.04% | 27.87% |
| Revenue growth | 10.50% | 16.70% |
| Dividend yield | 0.28% | 0.48% |
| Beta | 0.85 | 0.19 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
TMO vs REGN in plain English
- TMO is the bigger company — about 3.1× the market cap of REGN.
- REGN is cheaper on earnings (P/E 19.5 vs 36.4).
- REGN earns a higher return on equity (14% vs 14%).
- REGN is growing revenue faster (17% vs 10%).
- REGN has the higher dividend yield (0.48% vs 0.28%).
How would $1,000 have done in each?
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
REGN return calculator
See what $1,000 in Regeneron Pharmaceuticals, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.